TG Therapeutics, Inc.
Alış

TG Therapeutics forming 3rd base

82
Is a company that develops and commercializes novel treatments for B-cell diseases

The stock initiated a bull trend at the end of 2023 after a breakaway gap and has gained +90% during 2024 and gave 2 opportunities to buy on breakouts

Now is forming a 3rd base and may give another opportunity to enter, all this while relative to its sector XLV is making new highs

According to IBD is not among the industry leaders, but it has a 96 Relative Strength Rating against the SPX

Feragatname

Bilgiler ve yayınlar, TradingView tarafından sağlanan veya onaylanan finansal, yatırım, işlem veya diğer türden tavsiye veya tavsiyeler anlamına gelmez ve teşkil etmez. Kullanım Şartları'nda daha fazlasını okuyun.